Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2012
05/10/2012WO2012060590A2 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
05/10/2012WO2012059818A1 Methods of treatment using lipid compounds
05/10/2012WO2012059543A1 Composition containing calcium carbonate
05/10/2012WO2012059507A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012WO2012059432A1 N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the 5-ht6 receptor
05/10/2012WO2012059416A1 Pharmaceutical combinations for the treatment of metabolic disorders
05/10/2012WO2012027482A3 Compounds, compositions and methods related to ppar antagonists
05/10/2012WO2012026748A3 Pharmaceutical composition containing melastoma sanguineum extracts or fractions thereof as active ingredients for preventing and treating diabetic complications
05/10/2012WO2012021698A3 Treatment of diabetes with pancreatic endocrine precursor cells
05/10/2012WO2012021038A3 Composition for preventing and treating diabetes complications including spenceria ramalana extract or fraction thereof as active ingredient
05/10/2012WO2012021035A3 Composition for preventing and treating diabetes complications containing litsea japonica extract or fraction thereof as active ingredient
05/10/2012WO2012020021A9 Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases
05/10/2012WO2012019428A8 Benzohydrol derivatives, a preparation process and pharmaceutical use thereof
05/10/2012WO2012010977A8 Single daily dosage form for prevention and treatment of metabolic syndrome
05/10/2012WO2012006612A3 Use of trans-palmitoleate in identifying and treating metabolic disease
05/10/2012WO2012006014A3 Multi-component pharmaceuticals for treating diabetes
05/10/2012WO2011156715A3 Methods of treating metabolic disorders and cardiovascular diseases
05/10/2012US20120115964 Xanthan gum and swellable particulate containing composition and uses thereof
05/10/2012US20120115950 Abuse-resistant amphetamine prodrugs
05/10/2012US20120115946 Formulation
05/10/2012US20120115945 Ferric citrate dosage forms
05/10/2012US20120115941 Compounds Affecting Glycemic Index
05/10/2012US20120115936 Potent anti apob antisense compounds
05/10/2012US20120115934 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/10/2012US20120115933 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/10/2012US20120115931 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
05/10/2012US20120115926 Antisense modulation of apolipoprotein b expression
05/10/2012US20120115906 Derivatives of 3-alkoxy-4,5-diarylthiophene-2-carboxamide, preparation thereof, and therapeutic use thereof
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115902 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
05/10/2012US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115891 Method for the induction of a reward response by modulation of dopaminergic systems in the central nervous system
05/10/2012US20120115890 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
05/10/2012US20120115886 Fused pyrimidineone compounds as trpv3 modulators
05/10/2012US20120115882 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115865 New Salts of an Indole Derivative and Their Use in Medicine
05/10/2012US20120115864 Substituted Fused Pyrimidine Compounds
05/10/2012US20120115863 Compounds for the treatment of cns disorders
05/10/2012US20120115861 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/10/2012US20120115854 Pharmaceutical composition containing antihypertensive agents
05/10/2012US20120115851 Compound inhibiting in vivo phosphorus transport and medicine containing the same
05/10/2012US20120115850 Substituted arylamine compounds and methods of treatment
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115845 Therapeutic agents
05/10/2012US20120115843 Novel pyrrolidine derivatives
05/10/2012US20120115842 Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
05/10/2012US20120115838 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same
05/10/2012US20120115832 TGR5 Modulators and Methods of Use Thereof
05/10/2012US20120115824 Vitamin D Receptor Agonists and Uses Thereof
05/10/2012US20120115815 Compositions useful especially for treatment or prevention of metabolic syndrome
05/10/2012US20120115811 Phenylanaline amide derivatives useful for treating insulin-related diseases and conditions
05/10/2012US20120115803 Treatment of acinetobacter with alginate oligomers and antibiotics
05/10/2012US20120115799 Pharmaceutical formulations
05/10/2012US20120115779 Agent for suppressing elevation of blood triglyceride concentration
05/10/2012US20120115778 Methods of Suppressing Appetite by the Administration of Antagonists of the Serotonin HTR1a or HTR2b Receptors or Inhibitors of TPH2
05/10/2012US20120115777 Use of Ultrarapid Acting Insulin
05/10/2012US20120115776 Adiponectin-containing eating behavior control agent for oral administration
05/10/2012US20120114775 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
05/10/2012US20120114770 High amylose wheat
05/10/2012US20120114758 Beverage for pregnancy & lactation
05/10/2012US20120114742 Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
05/10/2012US20120114737 Silicone acrylate hybrid composition and method of making same
05/10/2012US20120114716 Flowable Carrier Matrix
05/10/2012US20120114706 Endorphin Therapy Compositions and Methods of Use Thereof
05/10/2012US20120114660 Antibodies Against LLG Polypeptides of the Triacylglycerol Lipase Family
05/10/2012US20120114659 Antibodies for Guanylyl Cyclase Receptors
05/10/2012US20120114654 Human antibodies to human tnf-like ligand 1a (tl1a)
05/10/2012US20120114653 Antibody therapy for treatment of diseases associated with gluten intolerance
05/10/2012US20120114644 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases
05/10/2012US20120114642 Targeting vegf-b regulation of fatty acid transporters to modulate human diseases
05/10/2012US20120114622 Lactobacillus rhamnosus and weight control
05/10/2012US20120114607 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
05/10/2012US20120114595 Sugar chain-added ailim extracellular domain and method for producing same
05/10/2012US20120114588 Ibat inhibitors for treatment of metabolic disorders and related conditions
05/10/2012US20120114558 Aptamer-mediated drug release
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012US20120114555 Method for treating immune disorders
05/10/2012CA2816949A1 Methods of treatment using lipid compounds
05/10/2012CA2816136A1 Crystalline forms of hydrochloride salt of (4a-r,9a-s) -1- (1h - benzoimidazole- 5 -carbonyl) -2, 3, 4, 4a, 9, 9a - hexahydro -1h- indeno [2, 1 -b] pyridine- 6 -carbonitrile and their use as hsd 1 inhibitors
05/10/2012CA2815611A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012CA2814357A1 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
05/10/2012CA2813671A1 Pharmaceutical combinations for the treatment of metabolic disorders
05/09/2012EP2450374A1 Peptide and use thereof
05/09/2012EP2450352A1 Prophylactic or therapeutic agent for cancer
05/09/2012EP2450084A1 Substances having body mass redistribution properties
05/09/2012EP2450044A1 Difructose anhydride-containing composition for use in inhibiting dental caries
05/09/2012EP2450042A1 Glucose metabolism-improving agent and glucose metabolism-improving composition
05/09/2012EP2450038A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof
05/09/2012EP2448962A1 Insulin derivatives
05/09/2012EP2448928A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
05/09/2012EP2448921A1 Aryl indole derivatives
05/09/2012EP2448591A2 Composition and method for reducing food intake
05/09/2012EP2448579A1 Eltoprazine for the treatment of weight disorders
05/09/2012EP2448432A1 Nutritional composition comprising cereal beta-glucan and salacia extract
05/09/2012EP2448412A1 Chromium complexes as enhancers of brain glucose transporters
05/09/2012EP2321308B1 Piperidine gpcr agonists
05/09/2012EP2318399B1 Piperidinyl gpcr agonists
05/09/2012EP2274297B1 Pyrrolidinone glucokinase activators
05/09/2012EP1968574B9 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
1 ... 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 ... 1298